Microrna-27a directly targets KRAS to inhibit cell proliferation in esophageal squamous cell carcinoma

Oncology Letters

Volumn 9, Issue 1, 2015, Pages 471-477

  Jiang, Yuzhi ^a   Duan, Yuting ^a   Zhou, Haibin ^a  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Cell proliferation; Esophageal cancer; KRAS gene; MicroRNA 27a

Indexed keywords

K RAS PROTEIN; MICRORNA; MICRORNA 27A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NONHUMAN; ONCOGENE K RAS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; VERY ELDERLY; WESTERN BLOTTING;

EID: 84911424431     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2701     Document Type: Article

References (36)

1. Lin SW, Abnet CC, Freedman ND, et al: Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma. BMC Cancer 13: 578, 2013.
2. Wu C, Li M, Hu C and Duan H: Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy. Cancer Chemother Pharmacol 73: 335-341, 2014.
3. Ku GY and Ilson DH: Adjuvant (postoperative) therapy for esophageal cancer. Thorac Surg Clin 23: 525-533, 2013.
4. Liu L, Zuo LF and Guo JW: Reversal of multidrug resistance by the anti-malaria drug artesunate in the esophageal cancer Eca109/ABCG2 cell line. Oncol Lett 6: 1475-1481, 2013.
5. Liu R, Yang M, Meng Y, et al: Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma. PLoS One 8: e77068, 2013.
6. Marks J, Rice DC and Swisher SG: Salvage esophagectomy in the management of recurrent or persistent esophageal carcinoma. Thorac Surg Clin 23: 559-567, 2013.
7. Migita K, Sho M, Shimada K, et al: Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma. Cancer 120: 808-817, 2014.
8. Moghbeli M, Forghanifard MM, Aarabi A, Mansourian A and Abbaszadegan MR: Clinicopathological sex-related relevance of Musashi1 mRNA expression in esophageal squamous cell carcinoma patients. Pathol Oncol Res: Oct 28, 2013 (Epub ahead of print).
9. Nurkin SJ, Nava HR, Yendamuri S, et al: Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer. Surg Endosc 28: 1090-1095, 2014.
10. Oze I, Matsuo K, Kawakita D, et al: Coffee and green tea consumption is associated with upper aerodigestive tract cancer in Japan. Int J Cancer 135: 391-400, 2014.
11. Paul S and Altorki N: Induction therapy for esophageal cancer. Thorac Surg Clin 23: 499-507, 2013.
12. Murata K, Ito H, Yoshitomi H, et al: Inhibition of miR-92a enhances fracture healing via promoting angiogenesis in a model of stabilized fracture in young mice. J Bone Miner Res 29: 316-326, 2014.
13. Menigatti M, Staiano T, Manser CN, et al: Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions. Oncogenesis 2: e56, 2013.
14. Guo L, Zhao Y, Zhang H, Yang S and Chen F: Close association between paralogous multiple isomiRs and paralogous/orthologues miRNA sequences implicates dominant sequence selection across various animal species. Gene 527: 624-629, 2013.
15. Chen Y, Min L, Zhang X, et al: Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer. Oncol Rep 30: 1832-1840, 2013.
16. Edelstein LC, McKenzie SE, Shaw C, et al: MicroRNAs in platelet production and activation. J Thromb Haemost 11 (Suppl 1): 340-350, 2013.
17. Gu J, Hu W, Wu J, et al: MiRNA genes of an invasive vector mosquito, Aedes albopictus. PLoS One 8: e67638, 2013.
18. Anwar SL, Albat C, Krech T, et al: Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. Int J Cancer 133: 660-670, 2013.
19. Biscontin A, Casara S, Cagnin S, et al: New miRNA labeling method for bead-based quantification. BMC Mol Biol 11: 44, 2010.
20. Chen X, Huang Z, Chen D, Yang T and Liu G: MicroRNA-27a is induced by leucine and contributes to leucine-induced proliferation promotion in C2C12 cells. Int J Mol Sci 14: 14076-14084, 2013.
21. No authors listed: Update of the NCCN guidelines for treatment of breast cancer. Oncology (Williston Park) 11: 199-220, 1997.
22. Zhang J, Lu Y, Yue X, et al: MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One 8: e70300, 2013.
23. Riedl CC, Slobod E, Jochelson M, et al: Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years. J Nucl Med 55: 1578-1583, 2014.
24. Kaspi H, Chapnik E, Levy M, et al: Brief report: miR-290-295 regulate embryonic stem cell differentiation propensities by repressing Pax6. Stem Cells 31: 2266-2272, 2013.
25. Liao WT, Li TT, Wang ZG, et al: MicroRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res 19: 4662-4672, 2013.
26. Lu J and Bushel PR: Dynamic expression of 3' UTRs revealed by Poisson hidden Markov modeling of RNA-Seq: implications in gene expression profiling. Gene 527: 616-623, 2013.
27. Pincini A, Tornillo G, Orso F, et al: Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells. Cell Cycle 12: 2409-2422, 2013.
28. Xu Q, He CY, Liu JW and Yuan Y: Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis. PLoS One 8: e65208, 2013.
29. Wang X, Wang ZH, Wu YY, et al: Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway. Mol Neurobiol 47: 373-381, 2013.
30. Lin XZ, Luo J, Zhang LP, et al: MiR-27a suppresses triglyceride accumulation and affects gene mRNA expression associated with fat metabolism in dairy goat mammary gland epithelial cells. Gene 521: 15-23, 2013.
31. Chen L, Hu X, Dai Y, et al: MicroRNA-27a activity is not suppressed in porcine oocytes. Front Biosci (Elite Ed) 4: 2679-2685, 2012.
32. Fletcher CE, Dart DA, Sita-Lumsden A, et al: Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer. Hum Mol Genet 21: 3112-3127, 2012.
33. Yoon KA, Yoon H, Park S, et al: The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg 144: 794-807, 2012.
34. Hezova R, Kovarikova A, Bienertova-Vasku J, et al: Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol 18: 2827-2831, 2012.
35. Huang Z, Chen X, Yu B, He J and Chen D: MicroRNA-27a promotes myoblast proliferation by targeting myostatin. Biochem Biophys Res Commun 423: 265-269, 2012.
36. Lü MH, Li CZ, Hu CJ, et al: MicroRNA-27b suppresses mouse MSC migration to the liver by targeting SDF-1α in vitro. Biochem Biophys Res Commun 421: 389-395, 2012.